好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting | Aducanumab: A Conversation with David Knopman About the Approval Process and the Future of Dementia Care

Tuesday 04/05/22
04:00 PM - 04:45 PM PDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Hubs (HeadTalks)
Joyce K. Lee-Iannotti, MD, FAAN, David Y. Hwang, MD, FAAN, David S. Knopman, MD, FAAN
General Neurology, Aging, Dementia, and Behavioral Neurology
Come learn more about the controversial use of Aducanumab as a treatment for Alzheimer’s disease from a leading authority in Cognitive and Behavioral Neurology, Dr. David Knopman.  Dr. Knopman will guide us in the development of aducanumab, the analysis of the clinical trial data, the approval by the FDA and the subsequent decision by CMS to limit coverage to persons in a controlled clinical trial. He will also update us on forthcoming treatments and the future of dementia care.
No CME available

Program Materials Program Evaluations

Event Timeline
04:00 PM - 04:45 PM PDT Discussion Aducanumab: A Conversation with David Knopman About the Approval Process and the Future of Dementia Care
Joyce K. Lee-Iannotti, MD, FAAN, David S. Knopman, MD, FAAN, David Y. Hwang, MD, FAAN
Faculty Disclosures
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Joyce K. Lee-Iannotti, MD, FAAN Dr. Lee-Iannotti has nothing to disclose.
David Y. Hwang, MD, FAAN The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. Dr. Hwang has received publishing royalties from a publication relating to health care. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Associate Medical Director with New England Donor Services.